The most common acute cardiac and pulmonary conditions requiring hospitalization exhibit significant clinical, pathophysiologic, and management strategies’ overlap that are often difficult to distinguish in the real world of practice. Such overlap has always been recognized with an obscure and largely unrecognized term “the heart lung disease (HLD)”. A very common manifested consequence of HLD is pulmonary hypertension, which involves distinct and heterogeneous causes and mechanisms that almost always involves faulty cardiopulmonary communication and, therefore, concurrent treatment may be common in typical in clinical practice. COVID-19 pandemic has been initially recognized as a disease that primarily affects the lungs, however with the accumulation of data, we now understand that it can be more fit as another manifestation of HLD. The recent COVID-19 pandemic has brought to the forefront of our attention and has surprised us with the fact that solid understanding and clear protocols of management from both worlds are necessary both at the bench and the bedside.
The goal of the Research Topic is the past, present, and future of the HLD. The section focusing on the past should involve revisiting pulmonary hypertension in patients with various cardiopulmonary scenarios such as left and right ventricular failure and pulmonary parenchymal and airway disease. It is important in this section to show the interaction and the pathological continuity between the heart and the lung in these conditions and the emerging role of the cardiopulmonary unit in the management and building up strategies and protocols of management. The section focusing on the present should involve the importance of HLD redefinition and re-understanding for the management of severe and critical COVID-19. Finally, the section focusing on the future should shed the light on how both worlds should come together for understanding post-COVID syndrome and how such efforts will benefit cardiopulmonary medicine at large.
Submissions are encouraged to focus on the following themes:
1) Heart Lung disease: The past, the present, and the future.
2) Right ventricular failure in patients with Pulmonary disease.
3) The overlap of pulmonary and cardiac pathology in the critical care units.
4) Cardiopulmonary critical care unit.
5) COVID-19: the heart, the lung, or both?
6) The role of Cardiopulmonary medicine in post-COVID syndrome.
The most common acute cardiac and pulmonary conditions requiring hospitalization exhibit significant clinical, pathophysiologic, and management strategies’ overlap that are often difficult to distinguish in the real world of practice. Such overlap has always been recognized with an obscure and largely unrecognized term “the heart lung disease (HLD)”. A very common manifested consequence of HLD is pulmonary hypertension, which involves distinct and heterogeneous causes and mechanisms that almost always involves faulty cardiopulmonary communication and, therefore, concurrent treatment may be common in typical in clinical practice. COVID-19 pandemic has been initially recognized as a disease that primarily affects the lungs, however with the accumulation of data, we now understand that it can be more fit as another manifestation of HLD. The recent COVID-19 pandemic has brought to the forefront of our attention and has surprised us with the fact that solid understanding and clear protocols of management from both worlds are necessary both at the bench and the bedside.
The goal of the Research Topic is the past, present, and future of the HLD. The section focusing on the past should involve revisiting pulmonary hypertension in patients with various cardiopulmonary scenarios such as left and right ventricular failure and pulmonary parenchymal and airway disease. It is important in this section to show the interaction and the pathological continuity between the heart and the lung in these conditions and the emerging role of the cardiopulmonary unit in the management and building up strategies and protocols of management. The section focusing on the present should involve the importance of HLD redefinition and re-understanding for the management of severe and critical COVID-19. Finally, the section focusing on the future should shed the light on how both worlds should come together for understanding post-COVID syndrome and how such efforts will benefit cardiopulmonary medicine at large.
Submissions are encouraged to focus on the following themes:
1) Heart Lung disease: The past, the present, and the future.
2) Right ventricular failure in patients with Pulmonary disease.
3) The overlap of pulmonary and cardiac pathology in the critical care units.
4) Cardiopulmonary critical care unit.
5) COVID-19: the heart, the lung, or both?
6) The role of Cardiopulmonary medicine in post-COVID syndrome.